The Delhi Court today has stayed the ban on 344 drugs after a six month long period of hearings on the petitions filed by the drugmakers.
Among the drugs which have been cleared of the ban include Vicks Action 500, Corex cough syrup and D’cold total manufactured by the leading pharmaceutical brands. For months now, the pharma industry had been hit with the court’s verdict for imposing the ban and suffered huge losses as well.
Delhi Court stays ban on 344 drugs, court’s decision comes as a big relief for the pharma industry
The banned drugs were said to be “irrational” since they were not required as better alternatives are available in the country as said by the central drug regulatory authority.
The verdict of the brand comes as a huge relief for the pharmaceutical industry in India. Initially, the ban was imposed by the Delhi court since it stated that the given drugs lacked the desired therapeutic properties as these claimed.
Over 450 petitions were filed by the drugmakers including Abbott, Procter & Gamble, Sanofi, Reckitt Benckiser, Glenmark, Cipla, Wockhardt and Lupin and many others.
The details of the current verdict have not been revealed as yet. The current stay on the ban would mean a halt to all the efforts of the government to remove the deleterious drugs from the market and also the case aginst the ineffectiveness of these drugs is yet to be proved as said by the reports. The attorney for the centre plans to take the matter to the apex court.